Abstract
Introduction: Hyperactive bladder syndrome after radical prostatectomy is a less common but serious disease that can have a major negative impact on quality of life. Method: A group of 500 patients after robot-assisted radical prostatectomy in 2016-2018 was evaluated.
Hyperactive bladder was assessed on the basis of micturition diaries 3 and 6 months after surgery. Results: The median follow-up was 36 months.
Overactive bladder syndrome was diagnosed in 15 (3 %) patients. First-generation anticholinergic therapy was effective in 12 (80 %) patients.
In three (20 %) patients, treatment was changed to solifenacin, which remained effective. After 6 months, the treatment was effective and did not need to be changed in the long term.
Conclusion: The incidence of overactive bladder syndrome was low in our cohort (3 %), which was less than in similar published studies. In most patients (80 %), first-generation anticholinergic therapy was effective.
If the therapeutic effect was insufficient or side effects occurred, treatment with solifenacin was effective.